Figure 1. Consort flow diagram.

Slides:

Advertisements

Similar presentations

Canadian Diabetes Association Clinical Practice Guidelines Management of Stroke in Diabetes Chapter 27 Michael Sharma, Gord Gubitz.

Advertisements

Diagnosis of diabetes. Diabetic symptoms Diabetic symptoms + venous sample for : –Random venous ≥ 11.1 mmol/l ( ) –Fasting glucose > 7(

Diabetes Prevention for a Heterogeneous Population Richard Arakaki, M.D. Professor of Medicine and Chief, Division of Endocrinology and Metabolism John.

Patient-directed titration to achieve glycaemic goals in type 2 diabetes using once-daily basal insulin: results of the TITRATE randomized controlled trial.

Date of download: 7/5/2016 From: Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes:

Figure 1. Mass of rapid insulin secretory bursts and ApEn values in young and old subjects. Increased Disorderliness of Basal Insulin Release, Attenuated.

Figure 2. ROC curves for fasting values (A) and OGTT values (B) for detecting insulin resistance in PCOS women. Sensitivity is plotted against 1 − specificity.

Copyright © 2003 American Medical Association. All rights reserved.

Figure 2. Summary of trial events

Figure 1. Twenty-four-hour plasma ACTH concentrations in insomniacs (▪) and controls (○). The thick black line indicates the sleep recording period. The.

Volume 26, Issue 2, Pages e2 (August 2017)

Fig. 1. Time line for investigations

Fig. 1. Kaplan-Meir survival curves for Stoke Cushing's patients, with follow-up duration in years on the x-axis. Number of patients in each subgroup is.

Fig. 1. Mean BMI and BMI Z-score (se) of the children with AA, TA, and TT genotypes in rs of the FTO gene. The P values are for the additive model.

Fig. 1. Correlation of TSH with TC, LDL-C, HDL-C, and TG.

Figure 2 Top panel shows mean (SE) differences in near-final height (cm) (n = 71) in the AI, GH, and AI/GH groups regardless of length of treatment (n.

Fig. 1. Study enrollment and disposition of participants

Fig. 2. Plasma melatonin secretion profiles for each of the eight subjects across the three conditions in the study. Profiles are shown for the entire.

Copyright © 2017 American Academy of Pediatrics.

Copyright © 2011 American Medical Association. All rights reserved.

A Trial of a Brief Group-Based Form of Acceptance and Commitment Therapy (ACT) for Chronic Pain in General Practice: Pilot Outcome and Process Results

Table 3. Predictors of Nevirapine Reactions at Antiretroviral Therapy Initiation From: Strategies for Nevirapine Initiation in HIV-Infected Children Taking.

Fig. 1. Left, Total ghrelin; right, octanoylated ghrelin

Fig. 4. Single total plasma 8-isoprostane levels in both controls and type 2 diabetic patients. Diabetes Induces p66shc Gene Expression in Human Peripheral.

Figure 1. Circadian pattern of gastric pH in healthy control subjects documented before (P1) Ramadan, on the 10th day (P2) and on the 24th day (P3) of.

Fig. 1. BAT activity before and after WL

Fig. 1. Effect of bariatric surgery on BMI and plasma leptin concentration. BMI (A) and plasma leptin concentrations (B) were determined in 27 morbidly.

Fig. 1. Flow of subjects through different phases of the study.

Quantified net intensity data are in arbitrary units (AU)

Fig. 1. Distribution of tetracycline labels (A) and MS/BS (B) in the TPTD and ZOL acid groups: values are medians (interquartile range). Representative.

Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288.

Fig. 1. Active GLP-1 and total PYY in response to a liquid test meal

Volume 136, Issue 1, Pages e2 (January 2009)

From: Low Vitamin D Status despite Abundant Sun Exposure

Fig. 1. Mean plasma lipid and lipoprotein levels as a function of the common genetic variants in LCAT, g.-293G>A, S208T, and L369L in the CCHS and S208T.

Figure 1. Total (A) and free (B) T, estradiol (C), and SHBG (D) levels at baseline and during treatment. From: Testosterone Treatment and Sexual Function.

Fig. 5. Histopathological study of the tumor tissue removed from patient 2. A, Macroscopic view of a tumor slice showing a dense tissue occupying the center.

Copyright © 2003 American Medical Association. All rights reserved.

Figure 1. TAK-448 structure (A) and effect on the hypothalamic-pituitary-gonadal axis (B). At the normal physiological state, GnRH pulses in the hypothalamus.

Predicted values and SEs were based on linear mixed models

Figure 1. Melatonin levels in CSF of control subjects (n = 82) and AD patients (n = 85). *, P< Decreased Melatonin Levels in Postmortem Cerebrospinal.

FIG. 1 Odds ratios (95% CIs) of metabolic syndrome and individual components calculated for clinical measures of periodontal disease (A and B). For gingival.

Fig. 3. Mean body weight of women randomized to low-carbohydrate and low-fat diets over the course of the 4-month trial. The first time point (wk 1) represents.

From: Is Age a Risk Factor for Hypothyroidism in Pregnancy

Fig. 1. Trial profile. From: Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the.

Triangles and dotted lines are for mean values. , P <

Diabetes and Pregnancy

Fig. 3. Plasma profiles of active GIP (A) and total GIP (B) concentrations after administration of single oral doses of sitagliptin 25 (white circles)

Fig. 4. Relationships of changes in CRP or SAA to changes in body weight and insulin resistance. For each comparison the regression line is shown (solid.

Figure 1. Correlations between TNFα and HOMA IR in men (•) and women (○). Circulating Tumor Necrosis Factor-α Concentrations in a Native Canadian Population.

Figure 1. MRI study demonstrating the change in visceral and sc abdominal fat area in a typical pioglitazone-treated patient. Each picture shows a transverse.

Fig. 1. Serum levels of IGF-I vs

Copyright © 2014 American Medical Association. All rights reserved.

with undiagnosed diabetes mellitus by three diagnostic criteria

Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study Cem Celik, M.D., Nicel.

A randomized controlled trial of a web-based education intervention for women with gestational diabetes mellitus Mary Carolan-Olah, Padaphet Sayakhot

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT ) V.B. Kraus, J. Birmingham,

Nat. Rev. Endocrinol. doi: /nrendo

Patient flow chart: the final prospective study population consisted of 521 individuals, 113 on basal insulin and 408 on OADs. *Plausibility: height (130–230 cm),

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled.

Volume 26, Issue 2, Pages e2 (August 2017)

Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288.

Receiver operating characteristic analyses showing area under the curves with reference to 2-hour OGTT (A,B) and fasting plasma glucose (C,D). HbA1c, glycated.

Flow of Patients Through Trial

Feasibility of a brief, intensive weight loss intervention to improve reproductive outcomes in obese, subfertile women: a pilot study Amy Rothberg, M.D.,

Volume 368, Issue 9541, Pages (September 2006)

Figure 1. Randomization and dropouts.

Fig. 3. (A) Least-squares (LS) mean difference in glycosylated hemoglobin (HbA1c) from baseline, and (B) LS mean difference in HbA1c from baseline over.

Clinical responses to therapy from baseline to week 24 and end point with last observation carried forward (LOCF). Clinical responses to therapy from baseline.

Presentation transcript:

Figure 1. Consort flow diagram. From: Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial J Clin Endocrinol Metab. 2017;102(5):1596-1605. doi:10.1210/jc.2016-3373 J Clin Endocrinol Metab | Copyright © 2017 Endocrine Society

Figure 2. RR of diabetes remission in the intervention groups compared with the control group based on the OGTT criteria. Complete diabetes remission was defined as a fasting plasma glucose < 6.1 mmol/L and 2-hour plasma glucose < 7.8 mmol/L on an OGTT and no chronic diabetes drugs. Partial or complete diabetes remission was defined as a fasting plasma glucose < 7.0 mmol/L and 2-hour plasma glucose < 11.1 mmol/L on an OGTT and no chronic diabetes drugs. From: Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial J Clin Endocrinol Metab. 2017;102(5):1596-1605. doi:10.1210/jc.2016-3373 J Clin Endocrinol Metab | Copyright © 2017 Endocrine Society

Figure 3. RR of diabetes remission and regression in the intervention groups compared with the control group based on the HbA1C criteria. Complete diabetes remission was defined as HbA1C < 6.0% (42 mmol/mol) and no chronic diabetes drugs. Partial or complete diabetes remission was defined as HbA1C < 6.5% (48 mmol/mol) and no chronic diabetes drugs. Diabetes regression or remission was defined as HbA1C < 7.0% (53 mmol/mol) and no chronic diabetes drugs. From: Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial J Clin Endocrinol Metab. 2017;102(5):1596-1605. doi:10.1210/jc.2016-3373 J Clin Endocrinol Metab | Copyright © 2017 Endocrine Society

Figure 4. Anthropometric outcomes Figure 4. Anthropometric outcomes. (a) Percentage weight change from baseline (─■─, 8-week group; ─▲─, 16-week group; ─○─, control group). Means and standard errors of the means are shown. For the 8-week intervention group compared with the control group, P = 0.001 at 8 weeks and P = 0.007 at 16 weeks. For the 16-week intervention group compared with the control group, P = 0.001 at 8 weeks, P = 0.0001 at 16 weeks, P < 0.0001 at 20 weeks, and P = 0.006 at 28 weeks. (b) Change in waist circumference from baseline (─■─, 8-week group; ─▲─, 16-week group; ─○─, control group). Means and standard errors of the means are shown. For the 8-week intervention group compared with the control group, P < 0.0001 at 8 weeks, P = 0.002 at 16 weeks, and P = 0.007 at 20 weeks. For the 16-week group compared with the control group, P = 0.002 at 8 weeks, P = 0.002 at 16 weeks, P = 0.001 at 20 weeks, and P = 0.01 at 28 weeks. From: Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial J Clin Endocrinol Metab. 2017;102(5):1596-1605. doi:10.1210/jc.2016-3373 J Clin Endocrinol Metab | Copyright © 2017 Endocrine Society